Additionally, episodes of dyskinesias in patients with ADCY5 mutations are noteworthy, consisting of severe, sleep-disrupting movements occurring during stages N2 and N3 of sleep (42, 43). The gene discussed is ADCY5; the disease is drug-induced dyskinesia.